User:VijayGorantla: Difference between revisions
(New page: right|thumb|Vijay S. Gorantla, MD, PHD '''Vijay S. Gorantla, MD, PHD''', Assistant Professor of Surgery, Administrative Director of Pittsburgh CTA Program, Div...) |
No edit summary |
||
| Line 6: | Line 6: | ||
'''Address:''' Vijay S. Gorantla, MD, PHD, Room 678 , Scaife Hall, 3550 Terrace Street, Pittsburgh, PA 15261 | '''Address:''' Vijay S. Gorantla, MD, PHD, Room 678 , Scaife Hall, 3550 Terrace Street, Pittsburgh, PA 15261 | ||
Dr. Vijay Gorantla is assistant professor of surgery in the division of plastic surgery at the University of Pittsburgh School of Medicine and administrative director of the Pittsburgh Composite Tissue Allotransplantation (CTA) program at UPMC. | Dr. Vijay Gorantla is assistant professor of surgery in the division of plastic surgery at the University of Pittsburgh School of Medicine and administrative director of the Pittsburgh Composite Tissue Allotransplantation (CTA) program at UPMC. | ||
Latest revision as of 20:19, 3 February 2009
Vijay S. Gorantla, MD, PHD, Assistant Professor of Surgery, Administrative Director of Pittsburgh CTA Program, Division of Plastic Surgery, University of Pittsburgh Medical Center
Contact: [1] ; Phone: 502-291-5294
Address: Vijay S. Gorantla, MD, PHD, Room 678 , Scaife Hall, 3550 Terrace Street, Pittsburgh, PA 15261
Dr. Vijay Gorantla is assistant professor of surgery in the division of plastic surgery at the University of Pittsburgh School of Medicine and administrative director of the Pittsburgh Composite Tissue Allotransplantation (CTA) program at UPMC.
Dr. Gorantla received his medical degree from the University of Health Sciences in India and pursued clinical training at King George Hospital. After surgical training in the United Kingdom, he completed a microsurgery and plastic and reconstructive surgery fellowship at the University of Louisville. He earned an M.S. and Ph.D. from the University of Louisville with a dissertation focused on the transplantation immunology of composite tissue allografts. He was a post-doctoral fellow in hand surgery at the Christine M. Kleinert Institute and played a key role in the hand transplant program at the University of Louisville.
Dr. Gorantla’s academic expertise and clinical research interests include clinical hand transplantation and novel immunomodulatory protocols directed at reducing long-term risk due to immunosuppressive drugs after CTA. His current experimental research at the Thomas E. Starzl Transplantation Institute addresses the role of local immunotherapy in targeting and minimizing skin immunogenicity and induction of tolerance after CTA.
Dr. Gorantla has authored numerous articles on composite tissue and hand transplantation and is editing a comprehensive book on the subject. He is a founding member of the American Society of Reconstructive Transplant Surgery and a member of the American Society of Reconstructive Microsurgery, the American Society of Surgery of the Hand, the American Society of Transplantation, the Transplantation Society, the Plastic Surgery Research Council and the Kleinert Society.